Cargando…
α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine
As a drug carrier, polyrotaxane (PR) has been used for targeted delivery and sustained release of drugs, whereas silver sulfadiazine (SD-Ag) is an emerging antibiotic agent. PR was synthesized by the use of α-cyclodextrin (CD) and poly(ethylene glycol) (PEG), and a specific antibacterial material (P...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415174/ https://www.ncbi.nlm.nih.gov/pubmed/30966226 http://dx.doi.org/10.3390/polym10020190 |
_version_ | 1783403129764577280 |
---|---|
author | Liu, Sa Zhong, Chunting Wang, Weiwei Jia, Yongguang Wang, Lin Ren, Li |
author_facet | Liu, Sa Zhong, Chunting Wang, Weiwei Jia, Yongguang Wang, Lin Ren, Li |
author_sort | Liu, Sa |
collection | PubMed |
description | As a drug carrier, polyrotaxane (PR) has been used for targeted delivery and sustained release of drugs, whereas silver sulfadiazine (SD-Ag) is an emerging antibiotic agent. PR was synthesized by the use of α-cyclodextrin (CD) and poly(ethylene glycol) (PEG), and a specific antibacterial material (PR-(SD-Ag)) was then prepared by loading SD-Ag onto PR with different mass ratios. The loading capacity and the encapsulation efficiency were 90% at a mass ratio of 1:1 of PR and SD-Ag. SD-Ag was released stably and slowly within 6 d in vitro, and its cumulative release reached more than 85%. The mechanism of PR loading SD-Ag might be that SD-Ag attached to the edge of α-CD through hydrogen bonding. PR-(SD-Ag) showed a higher light stability than SD-Ag and held excellent antibacterial properties against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). |
format | Online Article Text |
id | pubmed-6415174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64151742019-04-02 α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine Liu, Sa Zhong, Chunting Wang, Weiwei Jia, Yongguang Wang, Lin Ren, Li Polymers (Basel) Article As a drug carrier, polyrotaxane (PR) has been used for targeted delivery and sustained release of drugs, whereas silver sulfadiazine (SD-Ag) is an emerging antibiotic agent. PR was synthesized by the use of α-cyclodextrin (CD) and poly(ethylene glycol) (PEG), and a specific antibacterial material (PR-(SD-Ag)) was then prepared by loading SD-Ag onto PR with different mass ratios. The loading capacity and the encapsulation efficiency were 90% at a mass ratio of 1:1 of PR and SD-Ag. SD-Ag was released stably and slowly within 6 d in vitro, and its cumulative release reached more than 85%. The mechanism of PR loading SD-Ag might be that SD-Ag attached to the edge of α-CD through hydrogen bonding. PR-(SD-Ag) showed a higher light stability than SD-Ag and held excellent antibacterial properties against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). MDPI 2018-02-14 /pmc/articles/PMC6415174/ /pubmed/30966226 http://dx.doi.org/10.3390/polym10020190 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Sa Zhong, Chunting Wang, Weiwei Jia, Yongguang Wang, Lin Ren, Li α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine |
title | α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine |
title_full | α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine |
title_fullStr | α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine |
title_full_unstemmed | α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine |
title_short | α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine |
title_sort | α-cyclodextrins polyrotaxane loading silver sulfadiazine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415174/ https://www.ncbi.nlm.nih.gov/pubmed/30966226 http://dx.doi.org/10.3390/polym10020190 |
work_keys_str_mv | AT liusa acyclodextrinspolyrotaxaneloadingsilversulfadiazine AT zhongchunting acyclodextrinspolyrotaxaneloadingsilversulfadiazine AT wangweiwei acyclodextrinspolyrotaxaneloadingsilversulfadiazine AT jiayongguang acyclodextrinspolyrotaxaneloadingsilversulfadiazine AT wanglin acyclodextrinspolyrotaxaneloadingsilversulfadiazine AT renli acyclodextrinspolyrotaxaneloadingsilversulfadiazine |